/Companies

Healx

Cambridge, GB · Founded 2014 · 10 known investors

Find your way into Healx

438 people in our graph share verified history with the Healx team — schools, employers, funds. One of them is your warm intro.

Peter Craneunlockedknows Tim Guilliams · together at Innovation Forum (overlapped)
×11knows the team · via Cambridge Judge Business School

Healx uses artificial intelligence to redevelop, combine, and enhance known compounds to build a pipeline of therapies for rare diseases, with an expanding focus on oncology and preventing cancer recurrence. The company runs multiple drug discovery programmes in parallel, bringing candidate treatments from prediction through clinical trials.

Founders & leadership

Healx was founded in 2014 by Tim Guilliams and Dr David Brown.

TGTim Guilliams
Tim GuilliamsCo-founder, CEOTim Guilliams holds an MEng in Bio- and Chemical-Engineering from the University of Brussels and a PhD in Biophysics and Neuroscience from the University of Cambridge. He is co-founder and CEO of Healx, an AI-driven biotech company developing treatments for rare diseases and oncology.
DDDr David Brown
Dr David BrownCo-Founder and Board member

Investors · 10

Funding

SEC filings, press & company announcements

$47M disclosed across 1 of 3 rounds · 2019–2024

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

2 people who came through Healx went on to found or lead other companies.

Companies House · registry record

View on Companies House ↗
Registered name
HEALX LIMITED
Company number
09018507
Status
Active
Company type
Private limited company
Incorporated
30 Apr 2014
Registered office
3rd Floor Charter House, 66-68 Hills Road, Cambridge, CB2 1LA
Nature of business (SIC)
74909 — Other professional, scientific and technical activities n.e.c.
Previous names
HEALX3 LIMITED (2014–2015)
Accounts
last made up to 31 Dec 2024 · next due 31 Dec 2026
Confirmation statement
last made up to 30 Apr 2026 · next due 14 May 2027

Current officers · 6

  • Ohs Secretaries Limited — corporate secretary, appointed 14 Apr 2026
  • David Brown — director, appointed 15 Oct 2015
  • Suranga Chandratillake — director, appointed 18 Jun 2018
  • Laura Elizabeth Connell — director, appointed 4 Apr 2025
  • Tim Thomas Guilliams — director, appointed 30 Apr 2014
  • Jonathan Simon Milner — director, appointed 22 Jul 2016

Source: Companies House public register · retrieved 27 Sept 2026. Contains public sector information licensed under the Open Government Licence v3.0.

Frequently asked questions

What does Healx do?
Healx uses artificial intelligence to redevelop, combine, and enhance known compounds to build a pipeline of therapies for rare diseases, with an expanding focus on oncology and preventing cancer recurrence. The company runs multiple drug discovery programmes in parallel, bringing candidate treatments from prediction through clinical trials.
Who founded Healx?
Healx was founded by Tim Guilliams, Dr David Brown in 2014.
Who are Healx's investors?
Healx's investors include Amadeus Capital Partners, Aurum Venture Partners, Balderton Capital, Cambridge Angels group, Daniel Gutenberg, Intel Capital, SCI Ventures, VU Venture Partners and 2 more.
How much funding has Healx raised?
Healx has disclosed $47M raised across 1 of its 3 known rounds.
Where is Healx headquartered?
Healx is headquartered in Cambridge, GB.